We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
57 hedge funds and large institutions have $21.8M invested in Verrica Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
12% more funds holding
Funds holding: 51 → 57 (+6)
0.89% more ownership
Funds ownership: 3.23% → 4.12% (+0.89%)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
11% less call options, than puts
Call options by funds: $34K | Put options by funds: $38K
70% less capital invested
Capital invested by funds: $72.1M → $21.8M (-$50.3M)
Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
14
Reduced
14
Closed
16
Calls
$34K
Puts
$38K
Net Calls
-$4K
Net Calls Change
-$4K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$7.18M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.79M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.79M |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.26M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.61M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$3.46M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$2.91M |
| 3 |
BlackRock
New York
|
-$2.86M |
| 4 |
ACM
Altium Capital Management
New York
|
-$794K |
| 5 |
State Street
Boston,
Massachusetts
|
-$745K |
